SEP 03, 2015 6:00 AM PDT

MRSA Screening Program at a Community Healthcare System

Presented at: Microbiology
Speaker
  • Clinical Scientist in Microbiology, Immunology, and Molecular, Pathology Consultants of South Broward, LLP, Memorial Healthcare System
    Biography
      Rodney Arcenas earned a B.S. with Honors in Microbiology from the University of Florida in the spring of 1997. He continued his Microbiology training at the University Of South Florida College Of Medicine graduating in 2002 with a M.S. and Ph.D. in Medical Microbiology and Immunology. Dr. Arcenas was then accepted into the Clinical Microbiology Fellowship program at the Mayo Clinic in Rochester, MN. After completing his fellowship, he was hired in 2004 at LabOne, Inc. in Lenexa, Kansas to be their Scientific Director of Microbiology and Immunology. He left LabOne, Inc. in 2006 to join the Pathology Consultants of South Broward (PCSB) as their Clinical Scientist for Microbiology/Molecular Testing and has been there since. In his time with PCSB, Dr. Arcenas has helped to start the Molecular Infectious Disease testing service that has grown from a day-shift (8-hr, Mon - Fri) operation with 2 Medical Technologists to having 5 full time and 3 part time Medical Technologists with 24-hr shifts (Mon - Fri) and an abbreviated 1.5 shifts on the weekends. He also has helped spearhead the implementation of a successful MRSA active surveillance program that started in 2008. Dr. Arcenas is board certified as a Diplomate of the American Board of Medical Microbiology.

    Abstract

    Healthcare-associated infections (HAIs) continue to be a considerable problem for hospitals and healthcare institutions that can adversely affect patient outcomes and impact the financial bottom lines. There are a number of strategies hospitals may implement for combating and controlling HAIs. Methicillin Resistant Staphylococcus aureus (MRSA) is one of those HAIs that can cause significant morbidity and mortality. Minimizing or eliminating the potential for infection is one main driver for a hospital to consider and develop a screening/surveillance program. Other factors include pressures from states passing legislation requiring a MRSA program to be implemented and CMS's initiatives to prevent HAIs in general. The scope and clinical utility of a MRSA screening or active surveillance program is institution dependent and an assessment of the MRSA prevalence will help drive the decision to implement a formal Infection Control program. The identification of MRSA colonized patients is critical in directing Infection Control efforts towards limiting the risk of infection, and decreasing the likelihood that MRSA colonized patients become reservoirs of infection that could potentially be transmitted to other patients via the healthcare worker. In this presentation, we describe our successes and other lessons learned during our experiences in developing and implementing an active surveillance MRSA program in a large community healthcare system.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 03, 2015 6:00 AM PDT

    MRSA Screening Program at a Community Healthcare System

    Presented at: Microbiology

    Specialty

    Health

    Research

    Research And Development

    Human Genetics

    T-Cells

    Molecular Genetics

    University

    Bacteria

    Chronic Disease

    Earth Science

    Disease

    Drug Development

    Cell

    Geography

    North America67%

    Asia33%

    Registration Source

    Website Visitors100%

    Job Title

    Medical Laboratory Technician100%

    Organization

    Diagnostic Company33%

    Clinical Laboratory33%

    Manufacturer - Other33%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more